The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Integrative Research on Polysubstance Abuse and Addiction (R21/R33) |
323093, 323092, 323091, 323066 |
PAR-16-291 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) |
323030, 323038, 323049, 323052, 323032, 323054, 323035, 323045, 323037, 323048, 323043, 323039, 323033, 323029, 323046, 323053, 323040, 323042, 323031, 323044, 323036, 323041, 323050, 323051, 323047, 323026, 323027, 323028, 323034, 323007 |
PA-16-288 |
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) |
323011, 323023, 322961, 322957, 323014, 323013, 322964, 323022, 323009, 323017, 322965, 322966, 322960, 322958, 323025, 322956, 323008, 322959, 323015, 323018, 322955, 322962, 322963, 322967, 323016, 323010, 323020, 323021, 323019, 323024, 322954, 32 |
PA-16-289 |
| Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) |
322907, 322948, 322906, 322949 |
PAR-16-284 |
| Successor-in-Interest (Type 6 Parent) |
322941, 322992, 322970, 322996, 322977, 322999, 322994, 322982, 322998, 322973, 322993, 322971, 322968, 322978, 322943, 322945, 322940, 322942, 322946, 322969, 322990, 322976, 322991, 322987, 322975, 322979, 322989, 322995, 322972, 322974, 323001, 32 |
PA-16-286 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp) |
322932, 322919, 322929, 322920, 322909, 322882, 323081, 322918, 322923, 322927, 322916, 322925, 322917, 322883, 322915, 323082, 322880, 322910, 322933, 322926, 322931, 322921, 322924, 323083, 323084, 323085, 322886, 322934, 322884, 322908, 322914, 32 |
PA-16-287 |
| Change of Grantee Organization (Type 7 Parent) |
322839, 322841, 322863, 322871, 322866, 322873, 322851, 322864, 322854, 322845, 322848, 322865, 322846, 322858, 322847, 322842, 322833, 322840, 322836, 322834, 322832, 322867, 322870, 322853, 322844, 322852, 322855, 322849, 322856, 322868, 322872, 32 |
PA-16-285 |
| Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Specialized Center Cooperative Agreements (U54) |
322830, 322831 |
RFA-OD-16-011 |
| Prescription Drug Abuse (R21) |
322792, 322764 |
PA-16-232 |
| Standardization of C-peptide and HbA1c Measurements Program (UC4) |
322790, 322791 |
RFA-DK-16-011 |
| Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Resource Cooperative Agreement (U42) |
322813, 322814 |
RFA-OD-16-012 |
| Fogarty Global Health Training Program (D43) |
322752, 322750, 322749, 322751, 322741 |
RFA-TW-16-002 |
| Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) |
322781, 322780, 322782, 322783 |
PAR-16-280 |
| Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) |
322774, 322777, 322775, 322776, 322778 |
PAR-16-281 |
| Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) |
322772, 322773 |
PAR-16-278 |
| Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) |
322744, 322746, 322747, 322768, 322745, 322769 |
PAR-16-279 |
| Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21) |
322739, 322740 |
PAR-16-277 |
| Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) |
322736, 322737 |
PAR-16-276 |
| Serious Adverse Drug Reaction Research (R01) |
322670, 322668, 322669, 322661, 322662, 322665, 322666, 322663, 322664, 322667, 322671 |
PAR-16-275 |
| Serious Adverse Drug Reaction Research (R21) |
322650, 322653, 322651, 322656, 322655, 322657, 322654, 322652, 322659, 322658, 322660 |
PAR-16-274 |
| Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21) |
322606, 322607, 322648 |
PA-16-273 |
| Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01) |
322604, 322605, 322644 |
PA-16-263 |
| BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science (R25) |
322611, 322616, 322608, 322612, 322617, 322567, 322625, 322622, 322621, 322624, 322613, 322610, 322627, 322618, 322620, 322619, 322615, 322614, 322628, 322623, 322626, 322609, 322629 |
RFA-HG-16-016 |
| Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) |
322562, 322563, 322590 |
RFA-AI-16-047 |
| NIAID Clinical Trial Planning Grant (R34) |
322581, 322582, 322583 |
PAR-16-272 |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) |
322559, 322558, 322584 |
PAR-16-271 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) |
322555, 322556, 322557 |
PAR-16-270 |
| NIAID Clinical Trial Implementation Grant (R01) |
322553, 322554, 322580 |
PAR-16-269 |
| Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) |
322551, 322576 |
PAR-16-268 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01) |
322519, 322522, 322521, 322520, 322518, 322523 |
PAR-16-266 |
| NHLBI Career Transition Award for Intramural Fellows (K22) |
322531, 322529, 322528, 322532, 322530, 322533 |
PAR-16-267 |
| Reducing the Duration of Untreated Psychosis in the United States (R34) |
322503, 322504 |
PAR-16-264 |
| Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp) |
322464, 322466 |
PA-16-259 |
| Reducing the Duration of Untreated Psychosis in the United States (R01) |
322509, 322510 |
PAR-16-265 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) |
322484, 322486, 322485, 322501 |
PAR-16-262 |
| Methodology and Measurement in the Behavioral and Social Sciences (R01) |
322471, 322477, 322469, 322476, 322475, 322470, 322474, 322473, 322472, 322478 |
PAR-16-260 |
| Methodology and Measurement in the Behavioral and Social Sciences (R21) |
322447, 322446, 322468, 322444, 322440, 322443, 322441, 322442, 322445, 322463 |
PAR-16-261 |
| Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) |
322455, 322456 |
PA-16-258 |
| DoD Gulf War Illness Treatment Evaluation Award |
322390 |
W81XWH-16-GWIRP-TEA |
| Centers of Research Translation (CORT) (P50) |
322332, 322318 |
RFA-AR-17-001 |
Search Results 6281-6320 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
